14 December 2018 - - US-based synaptopathies drug developer Rodin Therapeutics has initiated a Phase 1 clinical trial of the company's lead candidate, RDN-929, a potent and selective HDAC-CoREST inhibitor, the company said.
The comp...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
14 December 2018 - - US-based life sciences and technology company InterVenn BioSciences has received an institutional investment of USD 9.4m led by seasoned biotech investor Genoa Ventures, with participation from True Ventures, Amplify Partners, Bo...
14 December 2018 - Autoimmune diseases company Eli Lilly and Company (NYSE:LLY) said on the US Food and Drug Administration's (FDA) fast track designation to facilitate the development and expedite the review of baricitinib for the treatment of ...
14 December 2018 - Medical diagnostics company Check-Cap Ltd (NASDAQ:CHEK) (NASDAQ:CHEKW), (NASDAQ:CHEKZ) reported on Thursday the receipt of the US Food and Drug Administration's (FDA) conditional approval for its Investigational Device Exempti...
14 December 2018 - SDC antimicrobial company PURE Bioscience Inc (OTCQB:PURE) stated on Thursday its net loss of USD2.6m (USD0.04 per share) for the fiscal first quarter ended 31 October 2018.This is compared with net loss of USD2.3m (USD0.04 per sha...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe